{
    "title": "Europe approves Amgen's first-in-class cholesterol drug",
    "url": "https://www.dailymail.co.uk/wires/ap/article-3169637/Europe-approves-Amgens-class-cholesterol-drug.html",
    "date": "2015-07-21",
    "keywords": [
        "cholesterol",
        "drug",
        "year",
        "heart",
        "substance",
        "decision",
        "analyst",
        "pcsk9",
        "percent",
        "europe",
        "gmt",
        "july",
        "amgen",
        "risk",
        "price",
        "ability",
        "commission",
        "repatha",
        "class",
        "sanofi",
        "pricing",
        "research",
        "firstinclass",
        "press",
        "email",
        "washington",
        "tuesday",
        "approval",
        "firstofakind",
        "decadesthe",
        "option",
        "disease",
        "attack",
        "death",
        "waxlike",
        "statin",
        "group",
        "saidrepatha",
        "treatment",
        "food",
        "administration",
        "regeneron",
        "target",
        "date",
        "lowdensity",
        "lipoprotein",
        "blood",
        "percentbut",
        "prospect",
        "pricey",
        "world",
        "health",
        "spokeswoman",
        "thousand",
        "inc",
        "tuesdayour",
        "consideration",
        "competition",
        "reimbursement",
        "environment",
        "patientcost",
        "sharing",
        "obligation",
        "country",
        "davis",
        "statementdeutsche",
        "bank",
        "robyn",
        "karnauskas",
        "time",
        "repathas",
        "noterepatha",
        "blockbuster",
        "prescribing",
        "problem",
        "pfizer",
        "mark",
        "schoenbaum",
        "label",
        "note",
        "afternoon",
        "trading"
    ],
    "category": [
        "wires",
        "ap"
    ]
}